The situation
A colleague of the principal scientist at a biotechnology company noticed a newly published patent application from a research institute overseas. The named inventor shared the scientist's name, and the claims read uncomfortably like the company's lead program. The colleague reported it through the internal ethics channel.
The general counsel had a publication, a common name and a serious possibility. She also had an employee with fifteen years of standing in his field, who might have nothing to do with it.
The question
Outside counsel instructed us on four points. Is the inventor the same person? Does he hold a role at the institute? Was that role disclosed? And how far does the institute's work overlap with the client's? The instruction was explicit that the first task was to test the innocent explanations.
What we did
An insider risk lead, a corporate records analyst, a scientific literature analyst and a language specialist worked the matter under privilege, with a red-team reviewer. The scope, agreed in writing, was limited to public professional records. Private accounts, personal life and anything about the scientist's background or nationality were out of bounds.
1. Established whether it was the same person
A shared name proves nothing. Three independent lines settled the question: a persistent researcher identifier attached to both sets of publications, a continuous co-author history that ran through both institutions, and a conference biography listing both affiliations beside the same photograph.
2. Tested whether the role was real
An honorary title would have been unremarkable. The public record showed more. The institute's annual report listed him as an adjunct group leader from early 2024. Four papers published since then acknowledged the institute's grant funding and gave it as his second affiliation. Two conference programs did the same. A funding body's published list of award recipients named him under a program whose public terms required recipients to file resulting intellectual property through the host institute.
3. Compared the disclosures
Counsel provided the scientist's outside-activity declarations. They recorded occasional guest lectures. They did not mention a funded position, a research group or the award.
4. Mapped the overlap
Two patent applications filed by the institute named him as an inventor. Both had priority dates after he joined the client. We compared their claims with the client's own earlier filings and identified the passages that overlapped, for counsel and the client's patent attorneys to assess.
5. Looked for what would clear him
The reviewer pressed three alternatives: a different person of the same name, a disclosed and approved arrangement, and a purely honorary affiliation. The first was excluded by the identifier and the co-author history. The second was contradicted by the declarations. The third was contradicted by the grant acknowledgments and the patents. A fourth possibility, that the institute's team had reached the same ideas independently, could not be tested from public sources at all.
| Record type | What it showed | Period |
|---|---|---|
| Institute annual report | Listed as adjunct group leader | From early 2024 |
| Grant acknowledgments | Institute funding and second affiliation on four papers | 2024 to 2026 |
| Conference programs | Dual affiliation in two speaker listings | 2025 |
| Funding award list | Named recipient under a program with public terms on intellectual property | 2024 |
What we found
- High confidence: the inventor and the client's principal scientist are the same person.
- High confidence: he had held a funded research post at the institute since early 2024, which his declarations did not disclose.
- High confidence: he is a named inventor on two applications whose claims overlap the client's lead program.
- Not determinable from open sources: whether those applications drew on work done at the client.
Whether the client's work had been used could only be answered from its own laboratory records. We said so plainly, listed the dated records that would settle it either way and stopped there. Reporting it as a finding would have been a guess with a career attached to it.
The outcome
Counsel received the report seventeen days after tasking and led an internal review that compared laboratory records with the patent claims.
- The scientist was shown the evidence and given the opportunity to respond. He acknowledged the post.
- His departure was agreed without litigation.
- The institute assigned both patent applications to the client as part of the settlement.
- The client rewrote its outside-activities policy and introduced declared-affiliation checks for sensitive research roles, at hiring and every two years, with the knowledge of the staff concerned.
What made the difference
Nothing in this case was hidden. An annual report, a list of award recipients and the acknowledgments section of four papers were all public. They had simply never been read together, by someone asking whether they agreed with a declaration form.
The restraint mattered as much as the research. The scope was set by the conduct in question, not by who the person was, and the one question that open sources could not answer was returned to the client unanswered.